Skip to main content

Table 1 Overview of measures administered at each assessment interval

From: Blended vs. face-to-face cognitive behavioural treatment for major depression in specialized mental health care: study protocol of a randomized controlled cost-effectiveness trial

Questionnaire

Aim

Baseline (T0)

Week 10 (T1)

Week 20 (T2)

Week 30 (T3)

Primary outcomes

     

IDS-SR

Depression severity

x

x

x

x

MINI plus full

Diagnostic interview

x

  

x

MINI plus; Section A

  

x

x

 

EQ-5D-3L

Health-related QoL

x

x

x

x

SF-36

Functional impairment

x

x

x

x

TiC-P

Health care utilization

x

x

x

x

Other variables of interest

     

General patient characteristics

x

   

A priori treatment preference

x

   

Mastery Scale

Locus of control

x

x

x

x

WAI-SR

Therapeutic alliance

 

x

  

CCL-D

Depressive cognitions

x

x

x

 

CSQ

Treatment satisfaction

   

x

SUS (bCBT only)

System usability

  

x

 
  1. bCBT: Blended Cognitive Behavioural Therapy; CCL-D: Cognition Checklist-Depression scale; CSQ: Client Satisfaction Questionnaire; EQ-5D-3L: EuroQol; IDS-SR: Inventory of Depressive Symptomatology, Self-Report version; MINI plus: Mini International Neuropsychiatric Interview Plus; QoL: Quality of Life; SF-36: 36-item Short Form Health Survey; SUS: System Usability Scale; TiC-P: Trimbos and iMTA questionnaire on Costs associated with Psychiatric illness; WAI-SR: Work Alliance Inventory-Short Revised.